Voluntary Scheme for Branded Medicines Pricing and Access

News

US and UK flags side by side blending into each other

UK and US agree zero tariffs on pharma – with price rises

A deal between the UK and the US will maintain tariffs on imports into the US at 0%, but prices of medicines used by the NHS will go up.

News

Rt Hon Wes Streeting MP, Secretary of State for Health and Social Care

As Streeting threatens no deal, talks on drug levy collapse

The UK government's threat to withdraw from negotiations on rebates paid by industry on NHS medicines has been followed by the collapse of talks.

Market Access

Time to ask companies why they don’t submit to NICE?

Companies can choose whether or not to submit to NICE to have their products appraised.

Views & Analysis

Achievement-so-far-on-objective-on-affordability

VPAS: Achievements so far on affordability

In the second part of this series taking stock of

Views & Analysis

VPAS: Achievement so far on objectives for patients

The UK has a voluntary agreement that was struck by the government and NHS England (now referred to as NHSE&I) with the Association of the British Pharmaceutical Industry (ABPI) in 2018

UK and US agree zero tariffs on pharma – with price rises

As Streeting threatens no deal, talks on drug levy collapse

Time to ask companies why they don’t submit to NICE?

VPAS: Achievements so far on affordability

VPAS: Achievement so far on objectives for patients

Iran hackers claim cyberattack at US medtech firm

Using AI-driven synthetic personas to take your insights fur...

Voluntary Scheme for Branded Medicines Pricing and Access

Editor's Picks